|
Q2 2021
Filed on Aug 11, 2021
|
5,831
|
N/A
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
2,491
|
N/A
|
|
Xeris Pharmaceuticals Inc
|
Q2 2021
Filed on Aug 11, 2021
|
99,860
|
N/A
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
28,966
|
$25.73 - $26.03
$745K - $754K
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
19
|
$42.36 - $54.56
$805 - $1.04K
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
310,396
|
N/A
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
500
|
$99.48 - $130.88
$49.7K - $65.4K
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
4,314
|
$123.49 - $160.08
$533K - $691K
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
39,662
|
$2.94 - $4.75
$117K - $188K
|
|
Catabasis Pharmaceuticals In
|
Q2 2021
Filed on Aug 11, 2021
|
11,801
|
N/A
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
11,872
|
$5.71 - $8.85
$67.8K - $105K
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
246
|
N/A
|
|
J P Morgan Exchange Traded F
|
Q2 2021
Filed on Aug 11, 2021
|
669
|
N/A
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
10,714
|
$4.03 - $7.57
$43.2K - $81.1K
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
10,147
|
N/A
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
35,000
|
$98.71 - $100.02
$3.45M - $3.5M
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
25,338
|
$48.18 - $48.51
$1.22M - $1.23M
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
90,681
|
N/A
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
10,120
|
N/A
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
38,900
|
$1.02 - $1.38
$39.7K - $53.7K
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
2,244,000
|
N/A
|
|
Nuance Communications Inc
|
Q2 2021
Filed on Aug 11, 2021
|
602,000
|
N/A
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
14,769
|
$52.74 - $53.49
$779K - $790K
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
1,639,000
|
N/A
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
11,089
|
$6.93 - $7.8
$76.8K - $86.5K
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
100
|
$32.97 - $35.75
$3.3K - $3.58K
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
4,336
|
$2.41 - $7.11
$10.4K - $30.8K
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
12,920
|
N/A
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
17,500
|
$2.08 - $2.81
$36.4K - $49.2K
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
57,942
|
$1.78 - $2.87
$103K - $166K
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
7,583
|
$4.68 - $9.39
$35.5K - $71.2K
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
71,696
|
$2.01 - $3.15
$144K - $226K
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
19,972
|
$1.88 - $3.56
$37.5K - $71.1K
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
4,133
|
$20.56 - $22.99
$85K - $95K
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
35
|
$16.6 - $18.94
$581 - $663
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
9,609
|
$3.08 - $5.13
$29.6K - $49.3K
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
25,117
|
$3.01 - $3.78
$75.6K - $94.9K
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
2,950,000
|
N/A
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
535,739
|
N/A
|
|
Richmond Mut Bancorporation
|
Q2 2021
Filed on Aug 11, 2021
|
7,745
|
N/A
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
2
|
N/A
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
6
|
$9.0 - $12.47
$54 - $74.8
|
|
Intercept Pharmaceuticals In
|
Q2 2021
Filed on Aug 11, 2021
|
397,000
|
N/A
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
1,450,000
|
N/A
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
7,971
|
N/A
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
3,700
|
$16.0 - $20.59
$59.2K - $76.2K
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
4,800
|
$4.7 - $16.7
$22.6K - $80.2K
|
|
|
Q2 2021
Filed on Aug 11, 2021
|
26,895
|
$1.93 - $3.72
$51.9K - $100K
|
|
Karyopharm Therapeutics Inc
|
Q2 2021
Filed on Aug 11, 2021
|
17,000
|
N/A
|
|
J P Morgan Exchange Traded F
|
Q2 2021
Filed on Aug 11, 2021
|
6,644
|
N/A
|
|